The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada
Clinical trial NCT01105507 · COMPLETED
Trial details
- NCT number
- NCT01105507
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-05-12
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.